Co-Authors
This is a "connection" page, showing publications co-authored by Bobbi Yarborough and Michael Leo.
Connection Strength
0.628
-
Reduced emergency department use among insured individuals receiving extended-release buprenorphine in a health system setting. Drug Alcohol Depend Rep. 2024 Jun; 11:100233.
Score: 0.244
-
Improvement in Body Image, Perceived Health, and Health-Related Self-Efficacy Among People With Serious Mental Illness: The STRIDE Study. Psychiatr Serv. 2016 Mar; 67(3):296-301.
Score: 0.136
-
STRIDE: a randomized trial of a lifestyle intervention to promote weight loss among individuals taking antipsychotic medications. BMC Psychiatry. 2013 Sep 28; 13:238.
Score: 0.118
-
An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications. Adm Policy Ment Health. 2016 07; 43(4):604-15.
Score: 0.036
-
Weight maintenance following the STRIDE lifestyle intervention for individuals taking antipsychotic medications. Obesity (Silver Spring). 2015 Oct; 23(10):1995-2001.
Score: 0.034
-
The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry. 2015 Jan; 172(1):71-81.
Score: 0.032
-
Recovery from serious mental illness: trajectories, characteristics, and the role of mental health care. Psychiatr Serv. 2013 Dec 01; 64(12):1203-10.
Score: 0.030